Skip to content

FES Assisted Cycling in Children With CP

Functional Electrical Stimulation Assisted Cycling to Improve Fitness and Strength in Children With Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04688424
Acronym
CP FES Cycling
Enrollment
39
Registered
2020-12-30
Start date
2008-04-30
Completion date
2016-06-30
Last updated
2020-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy Spastic Diplegia

Keywords

Cerebral Palsy, Functional electrical stimulation, Cycling

Brief summary

This project proposes to assess if Functional Electrical Stimulation (FES) assisted cycling can improve the cycling ability, muscle strength, cardiovascular health, quality of life, self perception and functional mobility of adolescents with CP better than a volitional cycling program or a non-intervention control group.

Detailed description

Aim 1: To compare the effects of 8-weeks of FES-assisted cycling training on improving cardiorespiratory fitness, walking function, self-motivated exercise/recreation, self-perception and functional mobility and quality of life of adolescents with spastic CP with marginal walking ability (Gross Motor Function Classification System Levels II - IV) vs. 8-weeks of volitional cycling training and a non-intervention control group. Aim 2: To compare the effects of 8-weeks FES-assisted cycling training on changes in cycling ability of adolescents with spastic CP with marginal walking ability vs. 8-weeks of volitional cycling training and a nonintervention control group. Aim 3: To elucidate the mechanisms for potential improvements in cycling ability after 8-weeks of FES-assisted or volitional cycling training of adolescents with spastic CP and marginal walking ability.

Interventions

DEVICEFES

FES will be applied via surface electrodes placed over bilateral quadriceps muscles. FES-stimulation will be ramped from sensory level (the level at which the individual feels a cutaneous sensation from the stimulation) to the maximum-tolerated level using a closed loop system controlled by computer software Subjects will exercise at home, three times per week, with FES on for 8 weeks with a goal of attaining 30 minutes of continuous cycling per session. If the individuals are unable to cycle for 30 continuous minutes, rest breaks will be provided with a goal of cycling for a total of 30 minutes. The length of each session will be approximately 45 minutes, with 15 minutes of set-up and 30 minutes of cycling.

OTHERCycling

Subjects will exercise at home, three times per week, without FES for 8 weeks with a goal of attaining 30 minutes of continuous cycling per session. If the individuals are unable to cycle for 30 continuous minutes, rest breaks will be provided with a goal of cycling for a total of 30 minutes. The length of each session will be approximately 45 minutes, with 15 minutes of set-up and 30 minutes of cycling.

Sponsors

Shriners Hospitals for Children
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Spastic CP (di-, tetra-, or triplegic) * Level II, III or IV GMFCS classification * Sufficient covering of the femoral head in the acetabulum (migration % \< 40) * Adequate range of motion of the hips, knees and ankles to allow pedaling * Visual, perceptual, cognitive, and communication skills to follow multiple step commands for attending to exercise and data collection * Seizure-free or well controlled seizures

Exclusion criteria

* Athetoid, ataxic, or hemiplegic CP * Significant scoliosis (primary curve \> 40°) * Spinal fusions extending into the pelvis * Severe tactile hypersensitivity * Joint instability or dislocation in LE * LE surgery or fractures in the past year * Botox injections to LE in the past 6 months * Severe spasticity in LE (Mod Ashworth 4) * LE joint pain during cycling * Hx of pulmonary disease limiting exercise tolerance or Hx of cardiac disease * Severely limited ROM / contractures that prevent the subject from being able to be safely positioned on the cycle * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in cycling AbilityOutcome assessed: Pre Training (week 0), Mid Training (week 4), Post Training (week 8), Follow-Up (week 16)Change in cycling cadence from pre-training to post-training and at follow-up will be assessed.
Change in Energy ExpenditureOutcome assessed: Pre Training (week 0), Mid Training (week 4), Post Training (week 8), Follow-Up (week 16)Energy expenditure is a measure of cardiovascular fitness. Change in energy expenditure from pre-training to post-training and at follow-up will be assessed.
Change in Gait speedOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Gait speed will be measured using a GAITRite Portable Walkway System (CIR Systems Inc; Havertown, PA). We will measure the change in gait speed from pre-training to post-training and at follow-up.
Change in Spatiotemporal gait parameterOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Step length will be measured using a GAITRite Portable Walkway System (CIR Systems Inc; Havertown, PA). We will measure the change in step length from pre-training to post-training and at follow-up.
Change in Muscle StrengthOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Isometric maximum voluntary exertion testing of hip extensors & flexors, knee extensors & flexors, and ankle plantarflexors. We will measure the change in isometric maximum voluntary exertion from pre-training to post-training and at follow-up.
Change in Walking DistanceOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)6 minute walk test (6MWT) measures walking distance. Walking distance (in a fixed period of time) is an indicator of endurance. We will measure the change in walking distance from pre-training to post-training and at follow-up.
Change in Timed Up-And-GoOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Timed Up-And-Go (TUG) is a measure of functional mobility and will allow for assessing the impact of anticipated improvements in motor control and gait biomechanics. We will measure the change in TUG test from pre-training to post-training and at follow-up.
Change in Pedometer measurementOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Pedometer measurements to allow an unbiased report of the subject's activity level at home and in the community. We will measure the change in pedometer measurements from pre-training to post-training and at follow-up.
Change in ElectromyographyOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Muscle activation timing measured with electromyography (EMG) during analysis allows for mechanistic study of anticipated improvements in motor control as well as comparison to typical norms. We will measure the change in EMG from pre-training to post-training and at follow-up.
Change in Self-AssessmentOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Canadian Occupational Performance Measure (COPM) is a 10 point scale to rate one's own level of performance and satisfaction with performance. 1 mean poor performance low satisfaction and 10 means very good performance high satisfaction. We will measure the change in COPM scores from pre-training to post-training and at follow-up.
Change in Health related Quality of LifeOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)The KINDL questionnaire is administered to measure changes in health-related quality of life. The questionnaire is completed by the adolescent and a caregiver. The KINDL standard scale and Disease Module is administered. The standard scale contains 24 items comprised of Physical, Emotional, Self-Esteem, Family, Friends and School sub-scales. The 6-item Disease Module that measures the child's and caregiver's perceptions about CP. Scores for each item ranges from 1-5. The total score is the sum of all item scores, transformed to a 0-100 scale. Higher scores indicate better quality of life. We will measure the change in KINDL scores from pre-training to post-training and at follow-up.
Change in Self-PerceptionOutcome assessed: Before Training (week 0), Mid Training (week 4), After Training (week 8), Follow-Up (week 16)Self-Perception (Piers-Harris-2) survey measures physical and emotional well-being and self-esteem and will allow assessment of the impact of anticipated improvements in motor control and gait biomechanics from training. We will measure the change in Piers-Harris scores from pre-training to post-training and at follow-up.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026